Zobrazeno 1 - 10 of 16 pro vyhledávání: '"A. G. L. Bodelier"'
1
Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry
Autor: Tessa Straatmijer, Fiona D. M. van Schaik, Alexander G. L. Bodelier, Marijn Visschedijk, Annemarie C. de Vries, Cyriel Y. Ponsioen, Marieke Pierik, Ad A. van Bodegraven, Rachel L. West, Nanne K. H. de Boer, Nidhi Srivastava, Tessa E. H. Romkens, Jildou Hoekstra, Bas Oldenburg, Gerard Dijkstra, Janneke C. van der Woude, Mark Löwenberg, Zlatan Mujagic, Vince B. C. Biemans, Andrea E. van der Meulen‐de Jong, Marjolijn Duijvestein
Publikováno v: Alimentary Pharmacology & Therapeutics, 57, 1, pp. 117-126
Alimentary Pharmacology & Therapeutics, 57, 117-126
Alimentary Pharmacology and Therapeutics, 57(1), 117-126
Alimentary Pharmacology and Therapeutics, 57(1), 117-126. Wiley-Blackwell
Straatmijer, T, van Schaik, F D M, Bodelier, A G L, Visschedijk, M, de Vries, A C, Ponsioen, C Y, Pierik, M, van Bodegraven, A A, West, R L, de Boer, N K H, Srivastava, N, Romkens, T E H, Hoekstra, J, Oldenburg, B, Dijkstra, G, van der Woude, J C, Löwenberg, M, Mujagic, Z, Biemans, V B C, van der Meulen-de Jong, A E & Duijvestein, M 2023, ' Effectiveness and safety of tofacitinib for ulcerative colitis : two-year results of the ICC Registry ', Alimentary Pharmacology and Therapeutics, vol. 57, no. 1, pp. 117-126 . https://doi.org/10.1111/apt.17248
Alimentary Pharmacology & Therapeutics, 57(1), 117-126. Wiley
Alimentary Pharmacology and Therapeutics, 57(1), 117-126. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology and Therapeutics, 57(1), 117-126. WILEY
Contains fulltext : 290620.pdf (Publisher’s version ) (Open Access) BACKGROUND: Tofacitinib is an oral Janus kinase (JAK) inhibitor and is registered for the treatment of ulcerative colitis (UC). The effectiveness of tofacitinib has been evaluated
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8627fcaccc449fd1031dddee12b17e7
https://doi.org/10.1111/apt.17248
Zobrazit plný text záznamu
2
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) a pragmatic, open-label, non-inferiority, randomised controlled trial
Autor: Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, Lisa J T Smits, Femke Atsma, Wietske Kievit, Dirk J de Jong, Annemarie C de Vries, Paul J Boekema, Rachel L West, Alexander G L Bodelier, Ingrid A M Gisbertz, Frank H J Wolfhagen, Tessa E H Römkens, Maurice W M D Lutgens, Adriaan A van Bodegraven, Bas Oldenburg, Marieke J Pierik, Maurice G V M Russel, Nanne K de Boer, Rosalie C Mallant-Hent, Pieter C J ter Borg, Andrea E van der Meulen-de Jong, Jeroen M Jansen, Sita V Jansen, Adrianus C I T L Tan, C Janneke van der Woude, Frank Hoentjen, Desirée van Noord, Jildou Hoekstra, Johannes T. Kamphuis, Moniek H.P. Gorter, Aura A.J. van Esch
Publikováno v: Lancet Gastroenterology & Hepatology, 8, 4, pp. 343-355
Lancet Gastroenterology & Hepatology, 8, 343-355
The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd
LADI study group and the Dutch Initiative on Crohn and Colitis 2023, ' Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) : a pragmatic, open-label, non-inferiority, randomised controlled trial ', The Lancet Gastroenterology and Hepatology, vol. 8, no. 4, pp. 343-355 . https://doi.org/10.1016/S2468-1253(22)00434-4
The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd.
Item does not contain fulltext BACKGROUND: Despite its effectiveness in treating Crohn's disease, adalimumab is associated with an increased risk of infections and high health-care costs. We aimed to assess clinical outcomes of increased adalimumab d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4a13f67ca392c8811058105e50cf3a
https://repository.ubn.ru.nl/handle/2066/293716
Zobrazit plný text záznamu
3
Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy
Autor: Ten Bokkel Huinink, Sebastiaan, Beelen, Evelien M.J., Ten Bokkel Huinink, Thomas, Hoentjen, Frank, G. L. Bodelier, Alexander, Dijkstra, Gerard, Romberg-Camps, Marielle, De Boer, Nanne K., Stassen, Laurents P.S., Van Der Meulen, Andrea E., West, Rachel, Van Ruler, Oddeke, Van Der Woude, C. Janneke, De Vries, Annemarie C.
Publikováno v: European Journal of Gastroenterology and Hepatology, 35(1), 45-51. Lippincott Williams and Wilkins
European Journal of Gastroenterology & Hepatology, 35(1), 45-51. LIPPINCOTT WILLIAMS & WILKINS
European Journal of Gastroenterology and Hepatology, 35(1), 45-51. Lippincott Williams & Wilkins
BACKGROUND: A considerable proportion of Crohn's disease patients that undergo ileocecal resection (ICR) have failed anti-tumor necrosis factor (TNF) therapy preoperatively. This study aimed to assess the effectiveness of retreatment of anti-TNF ther
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::56b237c704b10f2daa60865fe9c1b3e1
https://research.rug.nl/en/publications/425288a6-f16a-4dc2-b058-15859cdd57cf
Zobrazit plný text záznamu
5
DOP75 Effectiveness and Safety of tofacitinib versus vedolizumab in Patients with Ulcerative Colitis; A Nationwide, ICC Registry study
Autor: T Straatmijer, M Visschedijk, A de Vries, F Hoentjen, A A van Bodegraven, A G L Bodelier, N K H de Boer, G Dijkstra, E A M Festen, C Horjus, J M Jansen, B Jharap, W Mares, B Oldenburg, C Y Ponsioen, T E H Romkens, N Srivastava, M M van der Voorn, R L West, J C van der Woude, M D J Wolvers, M Pierik, A E van der Meulen, M Duijvestein
Publikováno v: Journal of Crohn's and Colitis. 16:i118-i120
Background Clinicians face difficulty in positioning biologics and JAK inhibitors in anti-TNF refractory ulcerative colitis (UC) patients. Head-to-head trials comparing the efficacy of vedolizumab and tofacitinib in UC patients are lacking. We aimed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::587c6d39aa1abb6cf5ebacdc5b22aa05
https://doi.org/10.1093/ecco-jcc/jjab232.114
Zobrazit plný text záznamu
6
Indications, postoperative management, and long-term prognosis of Crohn's disease after ileocecal resection: a multicenter study comparing the East and West
Autor: Jeanine H C Arkenbosch, Joyce W Y Mak, Jacky C L Ho, Evelien M J Beelen, Nicole S Erler, Frank Hoentjen, Alexander G L Bodelier, Gerard Dijkstra, Mariëlle Romberg-Camps, Nanne K H de Boer, Laurents P S Stassen, Andrea E van der Meulen, Rachel West, Oddeke van Ruler, Christien Janneke van der Woude, Siew C Ng, Annemarie C de Vries
Publikováno v: Inflammatory Bowel Diseases, 28(SUPPL 2), S16-S24. OXFORD UNIV PRESS INC
Inflammatory Bowel Diseases, 28(2). LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 28(SUPPL 2), S16-S24. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 28(2), S16-S24. John Wiley and Sons Inc.
Inflammatory Bowel Diseases, 28(2), S16-S24. Oxford University Press
Inflammatory Bowel Diseases, 28, SUPPL 2, pp. S16-S24
Inflammatory Bowel Diseases, 28, S16-S24
Arkenbosch, J H C, Mak, J W Y, Ho, J C L, Beelen, E M J, Erler, N S, Hoentjen, F, Bodelier, A G L, Dijkstra, G, Romberg-Camps, M, de Boer, N K H, Stassen, L P S, van der Meulen, A E, West, R, van Ruler, O, van der Woude, C J, Ng, S C & de Vries, A C 2022, ' Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection : A Multicenter Study Comparing the East and West ', Inflammatory Bowel Diseases, vol. 28, no. 2, pp. S16-S24 . https://doi.org/10.1093/ibd/izab316
Background The Crohn’s disease (CD) phenotype differs between Asian and Western countries and may affect disease management, including decisions on surgery. This study aimed to compare the indications, postoperative management, and long-term progno
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35cd59ceef1267511a2858e537f11cd8
http://hdl.handle.net/1887/3483747
Zobrazit plný text záznamu
7
Analysis of biomarkers and composite scores in IBD patients using probabilistic fuzzy systems
Autor: G. M. C. Adriaans, R. J. Almeida, D. Jonkers, T. van den Heuvel, A. G. L. Bodelier, M. J. Pierik
Publikováno v: 2022 IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS (FUZZ-IEEE)
The incidence of inflammatory bowel disease (IBD) is rising worldwide. Preventing disease progression by tight monitoring of disease activity using non-invasive procedures is important to prevent disease progression. In literature composite scores, c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e4f977a4744b69c7a69d5278fcfe3a
https://cris.maastrichtuniversity.nl/en/publications/22c8ab5d-d24d-48e4-9f39-b03403e79819
Zobrazit plný text záznamu
8
[Gastric perforation in Eastern European economic migrants]
Autor: Maarten A, Beek, Alexander G L, Bodelier, Rogier M P H, Crolla
Publikováno v: Nederlands tijdschrift voor geneeskunde. 163
The general prevalence of perforated peptic ulcers is decreasing and they are, therefore, more likely to be missed. In our hospital, Eastern European migrants are overrepresented in the population of patients with perforated gastric peptic ulcers; du
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a5c1a440e500fdd9eb8fde04c7fc5cd0
https://pubmed.ncbi.nlm.nih.gov/31050268
Zobrazit plný text záznamu
9
Symptomatic epidural lipomatosis in ectopic Cushing's syndrome
Autor: Alexander G L Bodelier, Wim Groeneveld, Harm R. Haak, Antonius N van der Linden
Publikováno v: European Journal of Endocrinology. :765-769
We report a case of spinal epidural lipomatosis (SEL) caused by ectopic Cushing's syndrome and give a review of the literature. The most common cause of SEL is prolonged therapy with glucocorticoids, only a very few cases are related to endogenous Cu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a72251eb0657a5507d3bbf97f50dffc
https://doi.org/10.1530/eje.0.1510765
Zobrazit plný text záznamu
10
Fasciola hepatica as a cause of jaundice after chewing khat: a case report
Autor: L C J, de Bree, A G L, Bodelier, G P, Verburg
Publikováno v: The Netherlands journal of medicine. 71(9)
Fasciola hepatica is a worldwide distributed zoonotic trematode incidentally infecting humans. Although often symptomatic, fascioliasis can cause a wide spectrum of disease. The diagnosis can be established by stool examination detecting ova of the p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bc29979b572d91001d268ad476ce9ab3
https://pubmed.ncbi.nlm.nih.gov/24218422
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje